Development of cell-penetrating peptide-conjugated antisense oligonucleotides for the treatment of Fascioscapulohumeral Muscular Dystrophy

Project: Research

StatusActive
Effective start/end date1/10/16 → …

Funding

Muscular Dystrophy UK: £71,342, Muscular Dystrophy UK: £71,303, Muscular Dystrophy UK: £72,333

Project relations

Prizes

Activities

Research outputs

ID: 37636275